ProCE Banner Activity

Antibody–Drug Conjugates in the Treatment of Cancer and Mechanisms of Ocular Toxicity

Slideset Download
Anthony Perissinotti, PharmD, BCOP describes the mechanism of corneal toxicity from antibody–drug conjugates used in the treatment of patients with cancer.

Released: December 15, 2020

Expiration: December 14, 2021

No longer available for credit.

Share

Faculty

Anthony Perissinotti

Anthony Perissinotti, PharmD, BCOP

Hematology Clinical Pharmacist Specialist
Clinical Team Leader
, Hematology/Oncology
Adjunct Clinical Assistant Professor
University of Michigan, Michigan Medicine
Roger Cancer Center
Ann Arbor, Michigan

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

GlaxoSmithKline

Faculty Disclosure

Primary Author

Anthony Perissinotti, PharmD, BCOP

Hematology Clinical Pharmacist Specialist
Clinical Team Leader
, Hematology/Oncology
Adjunct Clinical Assistant Professor
University of Michigan, Michigan Medicine
Roger Cancer Center
Ann Arbor, Michigan